No results for ‘’
Vivo Bio Tech Ltd
NSE: BSE: 511509
₹24.03
(0.33%)
Thu, 25 Jun 2026, 00:00 am
Market Cap (in Cr)53.32
PE Ratio0
Dividend0
Distribution Services
Medical Distributors
24.5KVivo Bio Tech Cashflow
| Particulars | 2011 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Deprecation and amortization | -20.82M | -55.91M | -74.47M | -92.66M | -92.91M | -90.17M |
| Accumulated depreciation, total | -48.42M | -256.24M | -305.73M | -370.21M | -434.14M | -496.99M |
| Cash from operating activities | 46.65M | 141.76M | 138.31M | 85.50M | 92.69M | 63.60M |
| Funds from operations | 61.93M | 112.74M | 96.48M | 119.15M | 118.17M | 116.84M |
| Net income (cash flow) | 7.07M | 56.82M | 22.02M | 26.49M | 25.26M | 72.83M |
| Depreciation & amortization (cash flow) | 20.76M | 55.91M | 74.47M | 92.66M | 92.91M | 90.17M |
| Depreciation/depletion | 16.85M | 35.88M | — | 64.48M | — | — |
| Amortization | 3.91M | 20.03M | — | 28.18M | — | — |
| Deferred taxes (cash flow) | 8.45M | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 34.09M | -29.37M | -22.71M | -19.72M | -15.34M | -61.25M |
| Changes in working capital | -15.28M | 29.02M | 41.83M | -33.65M | -25.48M | -53.24M |
| Cash from investing activities | -45.76M | -228.22M | -511.12M | -39.98M | -79.50M | -158.42M |
| Capital expenditures | -45.76M | -228.22M | -511.12M | -39.98M | -79.50M | -222.70M |
| Capital expenditures - fixed assets | -45.76M | -228.22M | -511.12M | -39.98M | -79.50M | -222.70M |
| Capital expenditures - other assets | — | — | — | 0 | 0 | — |
| Cash from financing activities | 1.02M | 87.83M | 378.28M | -48.91M | -13.04M | 93.72M |
| Free cash flow | 886.00K | -86.46M | -372.80M | 45.52M | 13.19M | -159.10M |